Gates Foundation Pneumonia Director Discusses India’s Child Immunization Program In Economic Times Interview

Economic Times: Gates foundation interested in preventing infectious diseases: Keith Klugman, Bill & Melinda Gates Foundation
“India is expected to roll out Pfizer’s 13-valent pneumococcal conjugate vaccine (PCV), Prevnar13, as part of its universal immunization program this year. The vaccine, procured from the Global Alliance for Vaccines and Immunization (Gavi) at $3.2-3.3 (Rs218-225) per dose, can prevent over half of pneumonia-related deaths in India, according to Keith Klugman, director for pneumonia, Bill & Melinda Gates Foundation. Klugman speaks to ET Pharma about how the government can succeed in combating pneumonia and related threats of antibiotic resistance with this launch…” (2/7).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.